|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Loans receivable, net | ||||||||||||||||||||
| Held for investment | ||||||||||||||||||||
| Real estate assets, net | ||||||||||||||||||||
| Beneficial interests in debt securities, available-for-sale, at fair value | ||||||||||||||||||||
| Held for sale | ||||||||||||||||||||
| Real estate assets, net | ||||||||||||||||||||
| Held for investment | ||||||||||||||||||||
| Held for sale | ||||||||||||||||||||
| Investments in unconsolidated joint ventures | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred leasing costs and intangible assets, net (including $8,241 and $9,872 related to real estate held for sale) | ||||||||||||||||||||
| Due from affiliates | ||||||||||||||||||||
| Other assets (including $12,707 and $3,704 related to real estate held for sale) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Secured financing ($126,193 and $0 related to consolidated VIE, respectively) | ||||||||||||||||||||
| Accrued and other liabilities (including $8,742 and $9,101 related to real estate held for sale) | ||||||||||||||||||||
| Due to affiliates—other | ||||||||||||||||||||
| Due to affiliates—contingent consideration | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Due to funds | ||||||||||||||||||||
| Total due to affiliates—contingent consideration | ||||||||||||||||||||
| Dividends and distributions payable | ||||||||||||||||||||
| Debt, net (including $103,524 and $8,769 related to assets held for sale) | ||||||||||||||||||||
| Convertible senior notes, net | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value per share; $625,750 liquidation preference; 50,000 shares authorized; 25,030 shares issued and outstanding | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Total preferred stock, $0.01 par value per share; $625,750 liquidation preference; 50,000 shares authorized; 25,030 shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value per share | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Total common stock, $0.01 par value per share | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Distributions in excess of earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Noncontrolling interests in investment entities | ||||||||||||||||||||
| Noncontrolling interests in Operating Company | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
